BICO Group AB (publ) (FRA:49Z)

Market Cap	121.74M -39.1%
Revenue (ttm)	138.35M -23.1%
Net Income	-100.62M
EPS	-1.43
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,500
Average Volume	3,399
Open	1.608
Previous Close	1.674
Day's Range	1.608 - 1.681
52-Week Range	1.469 - 3.958
Beta	n/a
RSI	50.81
Earnings Date	Feb 18, 2026

About BICO Group AB

BICO Group AB (publ) provides hardware, laboratory automation, and software solutions in North America, Europe, Asia, and internationally. It operates through three segments: Bioprinting, Life Science Solutions, and Lab Automation. The Bioprinting segment offers 3D bioprinters and bioinks with a range of technologies for various applications, resolutions, and volume/speed requirements, as well as provides services focused on accelerating drug discovery and development. The Life Science Solutions segment supplies lab instrumentation, consumables...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 2016
• Employees: 586
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 49Z

Financial Performance

In 2025, BICO Group AB's revenue was 1.50 billion, a decrease of -23.07% compared to the previous year's 1.95 billion. Losses were -1.09 billion, 19698.2% more than in 2024.

Financial numbers in SEK